Based on data from the STEP trials, onceweekly subcutaneous semaglutide 2.4 mg has been approved in Canada, Europe, the UK and the USA for chronic weight management in adults with overweight (with weightrelated comorbidities) or obesity
[55] Immune modulation and infection [edit] Semaglutide appears to influence the immune system through a complex gut-brain-immune network
How Fast Do You Lose Weight on Semaglutide
[46] A 2024 systematic review of 6 studies found that while lean body mass was unchanged in some cases, there were instances of significant decreases in lean body mass (040%)
In those cases, it is important to contact your provider so your treatment plan, dosage, nutrition, hydration, and overall health can be reviewed